|
Moving Forward in Multiple Myeloma |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Oncology 102: (On-Demand) 2026 - Nebraska Medicine |
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$0.00 |
|
Navigating Herbal and Supplement Use in Cancer Patients |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Beyond the Infusion Chair: Practical Implications of Subcutaneous Immunotherapies |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Closing the Gap: Optimizing AML Treatment in Aging Adults |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) 2025 |
- 19.25 AMA PRA Category 1 Credit™
- 19.25 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$150.00 |
|
Managing CAR T-cell Related Toxicities: The Acute, The Subacute, and The Chronic |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Fertility Preservation in Cancer Patients |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Integrative Oncology: A Patient Centered and Multidisciplinary Approach to Cancer Care (A Panel Discussion) |
- 1.00 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Radiation Oncology: Demystifying The Magic |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Supportive Care in Individuals with Head & Neck Cancer |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Fe-sponse Ready: Managing IV Iron Infusions with Confidence |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Living With Small Cell Lung Cancer (SCLC): Current Therapies and Looking Towards the Future |
- 0.50 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Old - Fred Hutch APP Onboarding Program - Oncology 102 |
- 19.25 AMA PRA Category 1 Credit™
- 19.25 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$0.00 |
|
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) 2026 |
- 19.25 AMA PRA Category 1 Credit™
|
Enduring |
|
$225.00 |